Impulse Dynamics announces the first implantation of the Optimizer IVs device in a patient with a concomitant S-ICD in the United States
Orangeburg, New York – July 28, 2015 – Impulse Dynamics (USA), Inc. announced that Cardiac electrophysiologist, Andrew Kaplan, M.D., FACC, FHRS became the first physician in the United States to implant the Optimizer™ IVs investigational device as part of the FIX-HF-5C FDA IDE protocol in a heart failure patient with a previously implanted subcutaneous (under the skin) implantable cardioverter defibrillator or S-ICD. (link CVAM) “It is exciting that as new technologies emerge we are able to see that the Impulse Dynamics technology is compatible with them: a true testament to the planning and engineering that went into the design process of the Optimizer,” said Dr. Kaplan.
About the Optimizer and CCM Therapy
CCM is the brand name for Cardiac Contractility Modulation, the non-excitatory electrical pulses delivered by the implantable Optimizer device during the absolute refractory period of the heart’s cardiac cycle to improve systolic contraction of the heart. The Optimizer System has been implanted in over 4,000 patients and is currently available in the US, Europe, China, Brazil, India, and more than 40 other countries around the world. Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, and the results have been published in over 80 articles appearing in leading medical journals.
About Impulse Dynamics
Impulse Dynamics is a medical device company dedicated to transforming the treatment of chronic heart failure. With global headquarters in Mount Laurel, N.J., the company has additional offices in; Stuttgart, Germany, Orangeburg, N.Y. and Curacao For more information please visit www.impulse-dynamics.com.
Impulse Dynamics (USA), Inc.
523 Fellowship Road, Suite 203
Mt. Laurel, NJ 08054